enow.com Web Search

  1. Ads

    related to: is farxiga fda approved for heart failure mayo clinic images

Search results

  1. Results from the WOW.Com Content Network
  2. Dapagliflozin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin

    Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

  3. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  4. AstraZeneca's Farxiga cuts death risk in heart failure ... - AOL

    www.aol.com/news/astrazenecas-farxiga-cuts-death...

    AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released ...

  5. What Does This New Diabetes Drug Mean for AstraZeneca and ...

    www.aol.com/news/2014-01-15-new-diabetes-drug...

    Recently, two pharmaceutical giants received FDA approval for a new treatment for type 2 diabetes. Farxiga (dapagliflozin) is a "sodium-glucose co-transporter 2 inhibitor", or SGLT2 inhibitor for ...

  6. Thiazolidinedione - Wikipedia

    en.wikipedia.org/wiki/Thiazolidinedione

    The main side effect of all thiazolidinediones is water retention, leading to edema, generally a problem in less than 5% of individuals, but a big problem for some and potentially, with significant water retention, leading to a decompensation of potentially previously unrecognized heart failure.

  7. Pharma Stock Roundup: FDA Approves Expanded Use of MRK ... - AOL

    www.aol.com/news/pharma-stock-roundup-fda...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Canagliflozin - Wikipedia

    en.wikipedia.org/wiki/Canagliflozin

    Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...

  9. Low carb diet may improve cholesterol levels in people with ...

    www.aol.com/low-carb-diet-may-improve-131000192.html

    Claudia Totir/Getty Images ... People with type 2 diabetes are at a higher risk of developing high cholesterol, which is a risk factor for heart disease. Traditionally, a high carbohydrate and low ...

  1. Ads

    related to: is farxiga fda approved for heart failure mayo clinic images